Joaquin Duato - Feb 14, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
CEO, Director
Signature
Raavi K. Deol, as attorney-in-fact for Joaquin Duato
Stock symbol
JNJ
Transactions as of
Feb 14, 2022
Transactions value $
-$397,811
Form type
4
Date filed
2/15/2022, 07:04 PM
Previous filing
Jan 19, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +5.42K +2.4% $0.00 232K Feb 14, 2022 Direct F1
transaction JNJ Common Stock Tax liability -$398K -2.36K -1.02% $168.85 229K Feb 14, 2022 Direct F2
holding JNJ Common Stock 784 Feb 14, 2022 By 401k F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -5.42K -100% $0.00* 0 Feb 14, 2022 Common Stock 5.42K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).